Tools
Tools
Patsouris, David, Müller, Michael 
ORCID: https://orcid.org/0000-0002-5930-9905 and Kersten, Sander
(2004)
Peroxisome proliferator activated receptor ligands for the treatment of insulin resistance.
Current Opinion in Investigational Drugs, 5 (10).
pp. 1045-1050.
ISSN 1472-4472
Abstract
Peroxisome proliferator activated receptors (PPARs) are a group of ligand-activated transcription factors that play critical roles in the regulation of energy metabolism. Synthetic agonists for these receptors are used in the treatment of type 2 diabetes mellitus and dyslipidemia. Current data linking PPAR and/or PPAR ligands with the treatment of insulin resistance will be critically reviewed, with the focus on important advances over the past year.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | animals,diabetes mellitus, type 2,humans,hypoglycemic agents,insulin resistance,ligands,peroxisome proliferator-activated receptors,sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being |
| Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
| UEA Research Groups: | Faculty of Medicine and Health Sciences > Research Groups > Nutrition and Preventive Medicine Faculty of Medicine and Health Sciences > Research Groups > Gastroenterology and Gut Biology Faculty of Medicine and Health Sciences > Research Centres > Metabolic Health |
| Related URLs: | |
| Depositing User: | Pure Connector |
| Date Deposited: | 07 Jul 2014 12:04 |
| Last Modified: | 25 Jun 2024 13:30 |
| URI: | https://ueaeprints.uea.ac.uk/id/eprint/47746 |
| DOI: |
Actions (login required)
 |
View Item |